Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Slgl Stock Analysis Sol Gel Technologies Ltd. Falls 4.84 To 79.46 Performance Breakdown 20260403 ECFA Ellsworth confirms stable scheduled preferred dividend payouts for the next four fiscal quarters CrossAsset Market Volatility and US Equity Correction Risks Amid Escalating Iran Conflict How sustainable is PureTech PRTC profit margins At Lows 20260508 How The GRX management quality drives results Slow Grind 20260506 Rhode Island Brewery Launches World Cup Beer Inspired by Iconic Soccer Chant What TPG RE TRTXs 127 Decline Means for Investors 20260515 Jim Cramer Warns SpaceX IPO Could Be Destructive for Broader Market Child Maintenance Service Errors Cause Financial Strain Parents Report Unfair Deductions Rise of the MultiJob Workforce Survival Mode Amid Rising Costs and Insecure Work Arm Holdings Surges 46 on Expectations of Fivefold Profit Growth Krispy Kreme Data Breach Settlement Deadline Approaches Who Qualifies Millennials and Gen Z Delay Life Milestones Causing Life Insurance Gap Report Finds Morrisons Plans to Close 100 Stores Amid Cost Pressures from Government Policies Intel Trading Volume Under Scrutiny Is INTC Among the Most Traded US Stocks in 2026 Biohaven Ltd BHVN Q1 2026 Earnings Wider Loss Than Expected as PreRevenue Biotech Advances Pipeline APEI Q1 2026 Earnings EPS Soars Past Estimates Stock Dips Slightly PureCycle Technologies Inc Unit PCTTU Q1 2026 Earnings Narrower Loss Than Expected as Operational Milestones Build Momentum LOCL Q1 2026 Earnings NarrowerThanExpected Loss Offers Modest Positive Surprise SPRY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment The9 Limited NCTY Faces Selling Pressure Tests Key Support Near 502 Bluejay Diagnostics BJDX Edges Higher as Shares Hold Above Key Support Terrestrial Energy Inc IMSR Surges Over 5 as Bullish Momentum Builds Jyong Biotech Ltd MENS Shows Resilience Uptick from Key Support Zone NovoCure NVCR Slumps 59 Testing Key Support at 1633